Zdrowie i gospodarka · 31/10/2022
FDA Announces Pilot Program to Expedite CMC Development for Regulated Products
The FDA is launching a limited pilot program to facilitate the expedited development of Chemistry, Manufacturing, and Controls for products under IND applications, with the goal of accelerating clinical development timelines and improving patient access to innovative treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →